Balancing Risk Versus Benefit in the Treatment of Waldenström's Macroglobulinemia Patients with Nucleoside Analogue–Based Therapy
Xavier Leleu(Hôpital Claude Huriez), Jérôme Tamburini(Pitié-Salpêtrière Hospital), Aldo M. Roccaro(Dana-Farber Cancer Institute), Pierre Morel(Centre Hospitalier de Lens), Jacob D. Soumerai(Dana-Farber Cancer Institute), Vincent Lévy(Pitié-Salpêtrière Hospital), Mathieu Wémeau(Hôpital Claude Huriez), Sandy Balkaran(Hôpital Claude Huriez), Stéphanie Poulain(Hôpital Claude Huriez), Zachary R. Hunter(Dana-Farber Cancer Institute), Irene M. Ghobrial(Dana-Farber Cancer Institute), Steven P. Treon(Dana-Farber Cancer Institute), Véronique Leblond(Sorbonne Université)
Cited by 41
Abstract
Related Papers
No related papers found
Powered by citation graph analysis